BioLineRx (BLRX) Profit After Tax Growth (1y) (2014 - 2025)
BioLineRx (BLRX) Profit After Tax Growth (1y) (2014 - 2025) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
PAT Growth (1y) (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
-88.68% |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
66.06% |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
17.05% |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
-129.68% |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
-290.15% |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
-632.44% |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
59.59% |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
- |
| 10 |
BioLineRx |
227.63 Mn |
211.90 Mn |
154,000.00 |
29.84% |
| Date | Value |
|---|
| Dec 31, 2025 |
29.84% |
| Sep 30, 2025 |
83.22% |
| Jun 30, 2025 |
714.05% |
| Mar 31, 2025 |
836.64% |
| Dec 31, 2024 |
77.05% |
| Sep 30, 2024 |
63.66% |
| Jun 30, 2024 |
-97.39% |
| Mar 31, 2024 |
94.28% |
| Dec 31, 2023 |
-142.26% |
| Sep 30, 2023 |
-134.01% |
| Jun 30, 2023 |
149.16% |
| Mar 31, 2023 |
-146.69% |
| Dec 31, 2022 |
-33.16% |
| Sep 30, 2022 |
-19.79% |
| Jun 30, 2022 |
8.78% |
| Mar 31, 2022 |
51.63% |
| Dec 31, 2021 |
64.10% |
| Sep 30, 2021 |
-23.78% |
| Jun 30, 2021 |
1.06% |
| Mar 31, 2021 |
-53.38% |
